drugset / Trial / NCT03308578

Statins and CPAP in Adipose Tissue of OSA

NCT03308578

RandomizedParallel-groupQuadruple-blindBasic science

Summary

This study is aimed at examining the alterations in adipose tissue in obstructive sleep apnea (OSA) patients in response to treatment with atorvastatin in continuation with standard treatment with continuous positive airway pressure (CPAP).

Timeline

Start
2018-01-08
Primary completion
2023-12-12
Completion
2023-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg